CompletedNot Applicable

Contrast Enhanced Intraoperative Ultrasound for Detection and Characterization of Renal Mass Undergoing Open Partial Nephrectomy

United States11 participantsStarted 2013-10

Plain-language summary

The goal of this clinical research is to learn how effective an ultrasound contrast agent, called DEFINITY, is when used during ultrasound-guided surgery to remove part of one or both kidneys.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients must have previous cross sectional imaging (CT or MRI) demonstrating renal mass or masses that is amenable to open partial nephrectomy.
✓. Patient is scheduled for intraoperative ultrasound guided open partial nephrectomy.
✓. Patient must sign informed consent, with risks and benefits of CEUS explained (see risks outlined on the following pages)

Exclusion criteria

✕. Patients with known renal mass scheduled for total or laparoscopic partial nephrectomy.
✕. Patients who are hypersensitive to Definity (Perflutren Lipid Microsphere)
✕. Patients with known history of right-to-left, bidirectional or transient right-to-left cardiac shunts.
✕. Pediatric patients less than 18 years of age.
✕. Pregnant or nursing mothers.

What they're measuring

Successful Capture of IO-CEUS Images

Timeframe: 1 day

Trial details

NCT IDNCT01894607

SponsorM.D. Anderson Cancer Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-12

Results submitted2016-02-17

View on ClinicalTrials.gov More Kidney Cancer trials